World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
28222
World Ranking
1869
National Ranking
74

Medicine

D-Index
76
Citations
28237
World Ranking
18648
National Ranking
688

Research.com Recognitions

  • 2018 - Member of Academia Europaea

Overview

Elisabeth H. Bel is affiliated with the University of Amsterdam in the Netherlands and focuses on research in the field of medicine, with a particular emphasis on pulmonary and respiratory medicine, physiology, surgery, immunology, and immunology and allergy. Their scholarly work spans multiple aspects of respiratory diseases and related therapies.

The researcher's prominent topics of study include:

  • Asthma and respiratory diseases
  • Respiratory and cough-related research
  • Eosinophilic esophagitis
  • Inhalation and respiratory drug delivery
  • IL-33, ST2, and ILC pathways
  • Allergic rhinitis and sensitization
  • Chronic obstructive pulmonary disease (COPD) research

Frequent collaborators in their research include Anneke Ten Brinke, Katrien Eger, Peter Howarth, Ratko Djukanović, and Simone Hashimoto. These coauthors have contributed consistently, indicating sustained scientific partnerships.

Their publications appear regularly in notable venues, including:

  • ERJ Open Research
  • The Journal of Allergy and Clinical Immunology In Practice
  • European Respiratory Journal
  • Allergy
  • Respiratory Medicine

Selected recent papers include:

  • Long-Term Therapy Response to Anti-IL-5 Biologics in Severe Asthma-A Real-Life Evaluation, 2020, The Journal of Allergy and Clinical Immunology In Practice
  • Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study, 2021, The Lancet Respiratory Medicine
  • Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics, 2020, European Respiratory Journal
  • Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study), 2021, European Respiratory Journal
  • From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases, 2021, Allergy

Throughout their career, Elisabeth H. Bel has contributed extensively to understanding severe asthma and eosinophilic diseases by investigating biologic therapies and personalized treatment approaches.

They were recognized in 2018 as a member of Academia Europaea, indicating a form of professional acknowledgment within the academic community.

Best Publications

  • International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

    Kian Fan Chung;Sally E. Wenzel;Jan L. Brozek;Andrew Bush

  • Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

    Elisabeth H. Bel;Sally E. Wenzel;Philip J. Thompson;Charlene M. Prazma

  • Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.

    J. K. Sont;L. N. A. Willems;E. H. Bel;J. H. J. M. Van Krieken

  • After asthma: redefining airways diseases

    Ian D Pavord;Richard Beasley;Alvar Agusti;Gary P Anderson

  • Treatable traits: toward precision medicine of chronic airway diseases.

    Alvar Agusti;Elisabeth Bel;Mike Thomas;Claus Vogelmeier

  • The prevalence of severe refractory asthma

    Pieter-Paul W. Hekking;Reinier R. Wener;Marijke Amelink;Aelko H. Zwinderman

  • Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.

    David Cheung;Mieke C. Timmers;Aeilko H. Zwinderman;Elisabeth H. Bel

  • Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

    Dominick E. Shaw;Ana R. Sousa;Stephen J. Fowler;Louise J. Fleming

  • Risk factors of frequent exacerbations in difficult-to-treat asthma

    ten A. Brinke;P.J. Sterk;A.A.M. Masclee;Ph. Spinhoven

  • An electronic nose in the discrimination of patients with asthma and controls

    Silvano Dragonieri;Robert Schot;Bart J.A. Mertens;Saskia Le Cessie

  • Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

    Matthieu Groh;Christian Pagnoux;Chiara Baldini;Elisabeth Bel

  • Factors associated with persistent airflow limitation in severe asthma.

    Anneke ten Brinke;Aeilko H. Zwinderman;Peter J. Sterk;Klaus F. Rabe

  • Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.

    Niki Fens;Aeilko H. Zwinderman;Marc P. van der Schee;Selma B. de Nijs

  • Chronic sinusitis in severe asthma is related to sputum eosinophilia.

    Anneke ten Brinke;Diana C. Grootendorst;Judith Th. Schmidt;Francisca T. de Bruïne

  • Severe asthma in adults: what are the important questions?

    Pascal Chanez;Sally E. Wenzel;Gary P. Anderson;Josep M. Anto

  • Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)

    E.H. Bel;A. Sousa;L. Fleming;A. Bush

  • Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma

    E. L. J. Van Rensen;K. C. M. Straathof;M. A. Veselic-Charvat;A. H. Zwinderman

  • Clinical phenotypes of asthma

    Elisabeth H. Bel

  • Adult-onset asthma: is it really different?

    Selma B. de Nijs;Lisette N. Venekamp;Elisabeth H. Bel

  • U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics

    Diane Lefaudeux;Bertrand De Meulder;Matthew J. Loza;Nancy Peffer

  • "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids.

    Anneke ten Brinke;Aeilko H. Zwinderman;Peter J. Sterk;Klaus F. Rabe

Frequent Co-Authors

Peter J. Sterk
Peter J. Sterk University of Amsterdam
René Lutter
René Lutter University of Amsterdam
Marc Humbert
Marc Humbert University of Paris-Saclay
Ratko Djukanovic
Ratko Djukanovic University of Southampton
Ian D. Pavord
Ian D. Pavord University of Oxford
David Price
David Price University of Aberdeen
Jørgen Vestbo
Jørgen Vestbo University of Manchester
Peter H. Howarth
Peter H. Howarth University of Southampton
Kian Fan Chung
Kian Fan Chung Imperial College London
Alvar Agusti
Alvar Agusti University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology in the USA opens doors to various healthcare and research careers. For those interested in clinical practice, accelerated nursing paths like the easiest absn to get into offer a swift transition into nursing roles. These programs are designed for students with prior degrees who want to quickly enter the nursing workforce.

If you prefer a more hands-on clinical role with shorter training, consider exploring the fastest and easiest lpn programs. Licensed Practical Nurses play vital support roles in immunology-related patient care, especially in community and rehabilitation settings.

For advanced practice, the easiest fnp program options can help students become Family Nurse Practitioners. This path suits those aiming to combine immunology expertise with primary care delivery.

Mental health is another critical sector connected to immunology, especially regarding neuroinflammation and psychiatric conditions. The best online psychiatric mental health nurse practitioner programs provide a strong clinical foundation with high placement rates, supporting careers focused on integrative mental health care.

Best Scientists Citing Elisabeth H. Bel

Trending Scientists

Recently Published Articles